At the time of writing, 89bio Inc [ETNB] stock is trading at $9.69, up 3.75%. An important factor to consider is whether the stock is rising or falling in short-term value. The ETNB shares have gain 5.10% over the last week, with a monthly amount drifted -5.19%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
89bio Inc [NASDAQ: ETNB] stock has seen the most recent analyst activity on March 14, 2025, when Goldman initiated its Neutral rating and assigned the stock a price target of $11. Previously, Citigroup started tracking the stock with Buy rating on March 13, 2025, and set its price target to $25. On February 04, 2025, Wolfe Research initiated with a Outperform rating. RBC Capital Mkts downgraded its rating to a Sector Perform and reduced its price target to $15 on January 12, 2024. Oppenheimer downgraded its rating to Perform for this stock on October 10, 2023. In a note dated August 28, 2023, UBS initiated an Buy rating and provided a target price of $36 on this stock.
For the past year, the stock price of 89bio Inc fluctuated between $4.16 and $11.84. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. 89bio Inc [NASDAQ: ETNB] shares were valued at $9.69 at the most recent close of the market. An investor can expect a potential return of 127.04% based on the average ETNB price forecast.
Analyzing the ETNB fundamentals
Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at -19204.19%, Pretax Profit Margin comes in at -18378.14%, and Net Profit Margin reading is -18413.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.56, Equity is -0.81 and Total Capital is -0.62. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that 89bio Inc [NASDAQ:ETNB] has a current ratio of 18.03. On the other hand, the Quick Ratio is 18.03, and the Cash Ratio is 8.33.
Transactions by insiders
Recent insider trading involved Le-Nguyen Quoc,, that happened on Jul 15 ’25 when 10461.0 shares were sold. Officer, QUOC LE-NGUYEN completed a deal on Jul 15 ’25 to buy 10461.0 shares. Meanwhile, Le-Nguyen Quoc sold 15329.0 shares on Apr 15 ’25.
